Article
Unveiling the Mechanisms to Bypass KRAS Inhibition: <i>In Vitro</i> Insights into the Influence of Fibroblast-Secretome
2024-04-23
Abstract excerpt
Novel KRAS-targeted therapies unlocked new treatment options for previously untreatable patients. However, in colorectal cancer (CRC), resistance to KRAS-targeted therapy develops rapidly, making it imperative to understand its underlying mechanisms. Cancer-associated fibroblasts (CAFs) induce therapy resistance by generating and maintaining cancer stem cells (CSCs). Additionally, CAFs secretome can modulate KRAS...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a3d96a5e-cc4f-51b0-b978-6a119d718c00
- DOI
- 10.1101/2024.04.19.590324
